Novo Nordisk: Novo Nordisk ties up with Metaphore to develop new obesity drugs

LONDON: Novo Nordisk signed a research tie-up with US biotech firm Metaphore on Thursday to develop next-generation obesity drugs.Why it’s Important Danish drugmaker Novo is trying to expand beyond its blockbuster obesity drug Wegovy with at least eight other treatments in its R&D pipeline for the condition. The collaboration will use Metaphore’s tech platform to … Read more

Drugs like Ozempic won’t ‘cure’ obesity but they might make us more fat-phobic

SYDNEY: Hundreds of thousands of people worldwide are taking drugs like Ozempic to lose weight. But what do we actually know about them? This month, The Conversation’s experts explore their rise, impact and potential consequences.Many have declared drugs like Ozempic could “end obesity” by reducing the appetite and waistlines of millions of people around the … Read more